154 related articles for article (PubMed ID: 30737159)
21. Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma.
Gershman B; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
Eur Urol; 2018 Dec; 74(6):825-832. PubMed ID: 30262341
[TBL] [Abstract][Full Text] [Related]
22. Impact of Perioperative Allogenic Blood Transfusion on Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
Rink M; Soave A; Dahlem R; Aziz A; Al-Sayed F; Peine S; Engel O; Kluth LA; Stenzl A; Burger M; Shariat SF; Fisch M; Fritsche HM; Gakis G
Clin Genitourin Cancer; 2016 Feb; 14(1):96-104. PubMed ID: 26506908
[TBL] [Abstract][Full Text] [Related]
23. Infectious complications associated with perioperative blood transfusion in partial or radical nephrectomy.
Hamilton ZA; Carbonella J; Siddiqui S; Al-Hammadi N; Hinyard L
Urol Oncol; 2021 Feb; 39(2):134.e17-134.e26. PubMed ID: 33250344
[TBL] [Abstract][Full Text] [Related]
24. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
25. Association between Perioperative Blood Transfusion and Oncologic Outcomes after Curative Surgery for Renal Cell Carcinoma.
Park YH; Kim YJ; Kang SH; Kim HH; Byun SS; Lee JY; Hong SH
J Cancer; 2016; 7(8):965-72. PubMed ID: 27313787
[TBL] [Abstract][Full Text] [Related]
26. Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma.
Andrade HS; Zargar H; Caputo PA; Akca O; Kara O; Ramirez D; Haber GP; Stein RJ; Kaouk JH
Eur Urol; 2016 Jun; 69(6):1149-54. PubMed ID: 26719014
[TBL] [Abstract][Full Text] [Related]
27. The impact of perioperative blood transfusion on survival and recurrence after radical prostatectomy for prostate cancer: A systematic review and meta-analysis.
Pushan Z; Manbiao C; Sulai L; Jun L; Ruidong Z; Hanshen Y
J Cancer Res Ther; 2018 Sep; 14(Supplement):S701-S707. PubMed ID: 30249890
[TBL] [Abstract][Full Text] [Related]
28. The effect of different timing of blood transfusion on oncological outcomes of patients undergoing radical cystectomy for bladder cancer: a systematic review and meta-analysis.
Ma SY; An Y; Sun JX; Xu MY; Liu CQ; Xu JZ; Zhong XY; Zeng N; He HD; Xia QD; Wang SG
Front Oncol; 2023; 13():1223592. PubMed ID: 37719020
[TBL] [Abstract][Full Text] [Related]
29. Predictive factors for perioperative blood transfusions in partial nephrectomy for renal masses.
Abu-Ghanem Y; Dotan Z; Kaver I; Ramon J
J Surg Oncol; 2015 Oct; 112(5):496-502. PubMed ID: 26437866
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Significance of Preoperative Anemia in Patients Undergoing Surgery for Renal Cell Carcinoma: A Meta-analysis.
Xia L; Hu G; Guzzo TJ
Anticancer Res; 2017 Jun; 37(6):3175-3181. PubMed ID: 28551661
[TBL] [Abstract][Full Text] [Related]
31. Renal functional outcomes after nephrectomy in patients with localized renal cell carcinoma and diabetes mellitus: a systematic review and meta-analysis.
Yang Y; Meng L; Hu X; Li X
Int Urol Nephrol; 2024 Jun; 56(6):1859-1868. PubMed ID: 38300449
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the long-term follow-up and perioperative outcomes of partial nephrectomy and radical nephrectomy for 4 cm to 7 cm renal cell carcinoma: a systematic review and meta-analysis.
Jiang YL; Peng CX; Wang HZ; Qian LJ
BMC Urol; 2019 Jun; 19(1):48. PubMed ID: 31174522
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Implication and Survival Outcomes of Perioperative Blood Transfusion on Urological Malignancies Undergoing Radical Surgical Intervention.
Mallick S; Mallik M; Chowdhury PS
Iran J Pathol; 2023; 18(1):33-48. PubMed ID: 37383156
[TBL] [Abstract][Full Text] [Related]
34. A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry.
Venkatramani V; Koru-Sengul T; Miao F; Nahar B; Prakash NS; Swain S; Punnen S; Ritch C; Gonzalgo M; Parekh D
Urol Oncol; 2018 Mar; 36(3):90.e9-90.e14. PubMed ID: 29254672
[TBL] [Abstract][Full Text] [Related]
35. Can partial nephrectomy provide equal oncological efficiency and safety compared with radical nephrectomy in patients with renal cell carcinoma (≥4cm)? A propensity score-matched study.
Lee H; Oh JJ; Byun SS; Jeong CW; Kwak C; Jeong BC; Jeon SS; Lee HM; Choi HY; Seo SI
Urol Oncol; 2017 Jun; 35(6):379-385. PubMed ID: 28284894
[TBL] [Abstract][Full Text] [Related]
36. Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and Radical Cystectomy.
Chalfin HJ; Liu JJ; Gandhi N; Feng Z; Johnson D; Netto GJ; Drake CG; Hahn NM; Schoenberg MP; Trock BJ; Scott AV; Frank SM; Bivalacqua TJ
Ann Surg Oncol; 2016 Aug; 23(8):2715-22. PubMed ID: 27012987
[TBL] [Abstract][Full Text] [Related]
37. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?
Capitanio U; Stewart GD; Klatte T; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Zaffuto E; Rodriguez Faba O; Salagierski M; Lingard J; Carini M; Ouzaid I; Mir MC; Montorsi F; Da Pozzo LF; Stief C; Minervini A; Brookman-May SD
Eur Urol Focus; 2018 Dec; 4(6):972-977. PubMed ID: 28753867
[TBL] [Abstract][Full Text] [Related]
38. Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience.
Petros FG; Metcalfe MJ; Yu KJ; Keskin SK; Fellman BM; Chang CM; Gu C; Tamboli P; Matin SF; Karam JA; Wood CG
World J Urol; 2018 Jul; 36(7):1093-1101. PubMed ID: 29488096
[TBL] [Abstract][Full Text] [Related]
39. The association of anxiety and depression with perioperative and oncologic outcomes among patients with clear cell renal cell carcinoma undergoing nephrectomy.
Packiam VT; Tyson Ii MD; Tsivian M; Lohse CM; Boorjian SA; Cheville JC; Costello BA; Leibovich BC; Thompson RH
Urol Oncol; 2020 Feb; 38(2):41.e19-41.e27. PubMed ID: 31761613
[TBL] [Abstract][Full Text] [Related]
40. A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma.
Morgan TM; Mehra R; Tiemeny P; Wolf JS; Wu S; Sangale Z; Brawer M; Stone S; Wu CL; Feldman AS
Eur Urol; 2018 May; 73(5):763-769. PubMed ID: 29249291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
